Anti-IL-6Ra/CD126 Antibody (Tocilizumab)
Catalog No.
F1212
Anti-IL-6Ra/CD126 Antibody (Tocilizumab)
Featured Products
Tocilizumab (Anti-Human IL6R, Humanized Antibody) is a neutralizing antibody against human interleukin-6 receptor (IL-6R) that blocks the binding of IL-6 to IL-6R, thereby inhibiting classical and trans Signal. Tocilizumab is being studied in rheumatoid arthritis. Tocilizumab has shown remarkable results in studies of severe COVID-19 viruses.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.2 kDa
Dry ice
375823-41-9
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Actemra, RoActemra, MRA
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P08887
Human, Cynomolgus
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Human IL-6R CHOs cells were stained with Anti-IL-6Ra/CD126 Antibody (Tocilizumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS
IL-6Ra / CD126
Please avoid freeze-thaw cycles.